Aster Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,417
Closed -$127K – 1129
2026
Q2
$127K Buy
+3,417
New +$105K 0.03% 474
2025
Q4
– Sell
-1,386
Closed -$37.7K – 1248
2025
Q3
$37.7K Buy
+1,386
New +$33.5K 0.02% 556
2025
Q2
– Sell
-3,898
Closed -$80.2K – 1290
2025
Q1
$80.2K Buy
3,898
+3,735
+2,291% +$79.6K 0.01% 708
2024
Q4
$4.19K Buy
+163
New +$4.62K ﹤0.01% 883

Other funds holding IDYA

Aster Capital Management's IDYA Position: Q3 2026 in Review

Aster Capital Management sold out of IDEAYA Biosciences (IDYA) in Q3 2026, closing a stake of 3,417 shares — an estimated $127K sold.

Aster Capital Management first reported a position in IDYA in Q4 2024 and held it in 4 quarters. The position peaked at $127K in Q2 2026. 281 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Aster Capital Management reported no remaining IDEAYA Biosciences position as of Q3 2026 after selling out during the quarter.
  • Aster Capital Management sold 3,417 IDEAYA Biosciences shares in Q3 2026, an estimated $127K.
  • Aster Capital Management first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 4 quarters.
  • Aster Capital Management's IDEAYA Biosciences position peaked at $127K in Q2 2026.
  • 281 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.